These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

493 related articles for article (PubMed ID: 24899173)

  • 1. MicroRNA miR-BART20-5p stabilizes Epstein-Barr virus latency by directly targeting BZLF1 and BRLF1.
    Jung YJ; Choi H; Kim H; Lee SK
    J Virol; 2014 Aug; 88(16):9027-37. PubMed ID: 24899173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epstein-Barr Virus MicroRNA miR-BART20-5p Suppresses Lytic Induction by Inhibiting BAD-Mediated caspase-3-Dependent Apoptosis.
    Kim H; Choi H; Lee SK
    J Virol; 2016 Feb; 90(3):1359-68. PubMed ID: 26581978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epstein-Barr virus miR-BART20-5p regulates cell proliferation and apoptosis by targeting BAD.
    Kim H; Choi H; Lee SK
    Cancer Lett; 2015 Jan; 356(2 Pt B):733-42. PubMed ID: 25449437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methylation profiling of Epstein-Barr virus immediate-early gene promoters, BZLF1 and BRLF1 in tumors of epithelial, NK- and B-cell origins.
    Li L; Su X; Choi GC; Cao Y; Ambinder RF; Tao Q
    BMC Cancer; 2012 Mar; 12():125. PubMed ID: 22458933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epstein-Barr Virus miR-BHRF1-3 Targets the BZLF1 3'UTR and Regulates the Lytic Cycle.
    Fachko DN; Chen Y; Skalsky RL
    J Virol; 2022 Feb; 96(4):e0149521. PubMed ID: 34878852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Viral genome methylation differentially affects the ability of BZLF1 versus BRLF1 to activate Epstein-Barr virus lytic gene expression and viral replication.
    Wille CK; Nawandar DM; Panfil AR; Ko MM; Hagemeier SR; Kenney SC
    J Virol; 2013 Jan; 87(2):935-50. PubMed ID: 23135711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellular immediate-early gene expression occurs kinetically upstream of Epstein-Barr virus bzlf1 and brlf1 following cross-linking of the B cell antigen receptor in the Akata Burkitt lymphoma cell line.
    Ye J; Gradoville L; Miller G
    J Virol; 2010 Dec; 84(23):12405-18. PubMed ID: 20861250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular transcription factor Oct-1 interacts with the Epstein-Barr virus BRLF1 protein to promote disruption of viral latency.
    Robinson AR; Kwek SS; Hagemeier SR; Wille CK; Kenney SC
    J Virol; 2011 Sep; 85(17):8940-53. PubMed ID: 21697476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of adenovirus vectors expressing Epstein-Barr virus (EBV) immediate-early protein BZLF1 or BRLF1 to treat EBV-positive tumors.
    Feng WH; Westphal E; Mauser A; Raab-Traub N; Gulley ML; Busson P; Kenney SC
    J Virol; 2002 Nov; 76(21):10951-9. PubMed ID: 12368338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of lytic Epstein-Barr virus (EBV) infection in EBV-associated malignancies using adenovirus vectors in vitro and in vivo.
    Westphal EM; Mauser A; Swenson J; Davis MG; Talarico CL; Kenney SC
    Cancer Res; 1999 Apr; 59(7):1485-91. PubMed ID: 10197618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rescue of the Epstein-Barr virus BZLF1 mutant, Z(S186A), early gene activation defect by the BRLF1 gene product.
    Adamson AL; Kenney SC
    Virology; 1998 Nov; 251(1):187-97. PubMed ID: 9813214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular Basis of Epstein-Barr Virus Latency Establishment and Lytic Reactivation.
    Murata T; Sugimoto A; Inagaki T; Yanagi Y; Watanabe T; Sato Y; Kimura H
    Viruses; 2021 Nov; 13(12):. PubMed ID: 34960613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epstein-Barr virus (EBV) EB1/Zta protein provided in trans and competent for the activation of productive cycle genes does not activate the BZLF1 gene in the EBV genome.
    Le Roux F; Sergeant A; Corbo L
    J Gen Virol; 1996 Mar; 77 ( Pt 3)():501-9. PubMed ID: 8601788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. De novo protein synthesis is required for lytic cycle reactivation of Epstein-Barr virus, but not Kaposi's sarcoma-associated herpesvirus, in response to histone deacetylase inhibitors and protein kinase C agonists.
    Ye J; Gradoville L; Daigle D; Miller G
    J Virol; 2007 Sep; 81(17):9279-91. PubMed ID: 17596302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fatty acid synthase expression is induced by the Epstein-Barr virus immediate-early protein BRLF1 and is required for lytic viral gene expression.
    Li Y; Webster-Cyriaque J; Tomlinson CC; Yohe M; Kenney S
    J Virol; 2004 Apr; 78(8):4197-206. PubMed ID: 15047835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 5-hydroxymethylation of the EBV genome regulates the latent to lytic switch.
    Wille CK; Nawandar DM; Henning AN; Ma S; Oetting KM; Lee D; Lambert P; Johannsen EC; Kenney SC
    Proc Natl Acad Sci U S A; 2015 Dec; 112(52):E7257-65. PubMed ID: 26663912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Epstein-Barr virus Rta protein activates lytic cycle genes and can disrupt latency in B lymphocytes.
    Ragoczy T; Heston L; Miller G
    J Virol; 1998 Oct; 72(10):7978-84. PubMed ID: 9733836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nuclear factor-Y and Epstein Barr virus in nasopharyngeal cancer.
    Chia MC; Leung A; Krushel T; Alajez NM; Lo KW; Busson P; Klamut HJ; Bastianutto C; Liu FF
    Clin Cancer Res; 2008 Feb; 14(4):984-94. PubMed ID: 18281530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epstein-Barr virus BZLF1 gene, a switch from latency to lytic infection, is expressed as an immediate-early gene after primary infection of B lymphocytes.
    Wen W; Iwakiri D; Yamamoto K; Maruo S; Kanda T; Takada K
    J Virol; 2007 Jan; 81(2):1037-42. PubMed ID: 17079287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Editing of Epstein-Barr virus-encoded BART6 microRNAs controls their dicer targeting and consequently affects viral latency.
    Iizasa H; Wulff BE; Alla NR; Maragkakis M; Megraw M; Hatzigeorgiou A; Iwakiri D; Takada K; Wiedmer A; Showe L; Lieberman P; Nishikura K
    J Biol Chem; 2010 Oct; 285(43):33358-33370. PubMed ID: 20716523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.